Our range of services
Centrum HTA provides consultancy services related to the pharmaceutical market in Poland. The company’s activities cover a wide range of services related to Health Technology Analyses dossiers in a reimbursement procedure.
FULL HEALTH TECHNOLOGY ASSESSMENT (HTA) DOSSIER
- Decision Problem Analysis
- Clinical analysis
- Economic analysis
- Budget Impact Analysis
- Rationalization Analysis
CHARACTERISTICS OF THE PHARMACEUTICAL MARKET IN POLAND
REVIEW OF EPIDEMIOLOGICAL AND COST SPECIFIC DATA IN THE POLISH SETTINGS
SYSTEMATIC REVIEW OF CLINICAL TRIALS
BUDGET IMPACT ANALYSIS FOR GENERIC DRUGS
FULL TEXT PUBLICATIONS
WORKSHOPS
ON EBM AND HTA
ADVISORY BOARDS
SCIENTIFIC CONFERENCES DOSSIERS
FULL RANGE REIMBURSEMENT CONSULTING
HTA ANALYSES ARE DEVELOPED BY THE CENTRE HTA TEAM WITH GREAT PRECISION IN ACCORDANCE WITH THE FOLLOWING REQUIREMENTS
Act of May 12, 2011 on reimbursement of medicines, foodstuffs for particular nutritional purposes and medical devices (as amended)
Regulations of the Minister of Health of 24 September 2023 on the minimum requirements to be satisfied by the analyses included in applications for reimbursement and for setting the official retail price and for increasing the official retail price of a medicinal product, a special-purpose food supplement, a medical device which does not have a reimbursed counterpart in a given indication.
Health Technology Assessment Guidelines Version 3.0 Warsaw, August 2016 (publication date 14 of September 2016)